The anti-proliferative gene TIS21 is involved in osteoclast differentiation

J Biochem Mol Biol. 2002 Nov 30;35(6):609-14. doi: 10.5483/bmbrep.2002.35.6.609.

Abstract

The remodeling process of bone is accompanied by complex changes in the expression levels of various genes. Several approaches have been employed to detect differentially-expressed genes in regard to osteoclast differentiation. In order to identify the genes that are involved in osteoclast differentiation, we used a cDNAarray-nylon membrane. Among 1,200 genes that showed a measurable signal, 19 genes were chosen for further study. Eleven genes were up-regulated; eight genes were downregulated. TIS21 was one of the up-regulated genes which were highly expressed in mature osteoclasts. To verify the cDNA microarray results, we carried out RT-PCR and real-time RT-PCR for the TIS21 gene. The TIS21 mRNA level was higher in differentiated-osteoclasts when compared to undifferentiated bone-marrow macrophages. Furthermore, the treatment with 1 mM of a TIS21 antisense oligonucleotide reduced the formation of osteoclasts from the bone-marrow-precursor cells by approximately 30%. These results provide evidence for the potential role of TIS21 in the differentiation of osteoclasts

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Line
  • Cells, Cultured
  • DNA, Complementary / metabolism
  • Down-Regulation
  • Genes, Tumor Suppressor*
  • Immediate-Early Proteins / chemistry*
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / physiology*
  • Macrophages / metabolism
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • Oligonucleotides, Antisense / pharmacology
  • Osteoclasts / cytology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Suppressor Proteins
  • Up-Regulation

Substances

  • Btg2 protein, mouse
  • DNA, Complementary
  • Immediate-Early Proteins
  • Oligonucleotides, Antisense
  • Tumor Suppressor Proteins